TREDEGAR CORP (TG) stock intrinsic value fair value estimate & owner earnings analysis

Tredegar today is a much smaller company than its ten-year record suggests. It sold its personal care films business in 2020 and its Brazilian flexible packaging operation, Terphane, in November 2024, and what is left is two businesses: Bonnell Aluminum, a US custom aluminum extruder serving building and construction, automotive, electrical and distribution customers, and High Performance Films, which makes surface protection films for electronics manufacturers and thin packaging films for tissue and towel. Because of those exits, and because reported cash flow in 2022 and 2023 was dominated by roughly $78 million of one-time cash contributions to terminate the company's pension plan, only 2025 is a clean full year for the business as it now stands, so we have valued it on that shortened history rather than the full decade. Owner earnings per share on the reported whole-company numbers ran $1.13 in 2021, negative $1.81 in 2022, negative $0.13 in 2023, $0.25 in 2024 and $0.40 in 2025. Normalising 2025 for an unusually large working capital build in a year when sales grew 21 percent, and for about $6 million of professional fees on transaction work that management says will not repeat, points to sustainable owner earnings closer to $26 million, or roughly $0.75 per share. The pension question that overhung this company for years is now closed: the qualified plan was terminated and annuitised in 2023, the retiree medical plan was wound up in 2025, and only a $1.4 million unfunded supplemental obligation remains. The sale of the Brazilian business is likewise settled, with the final post-closing payment received in early 2025 and nothing further carried as receivable. Borrowings are modest at about $46 million against $17 million of cash, on a revolving facility committed to 2030 that still had $87.5 million available to draw at year end, with lease commitments of a further $13 million. The values below are stated after deducting that borrowing. The base case assumes segment profits hold near 2025 levels and grow about two percent a year, discounted at ten percent, and comes to $9.49 a share. The bear case is grounded in the company's own worst recent stretch, 2023, when the films business earned less than half its current profit and extrusion volumes were weak, and assumes that level of earning power persists for a decade with essentially no recovery, discounted at twelve percent; it comes to $2.93. That downside is a live risk rather than a theoretical one: extrusion is capital intensive and heavy in fixed costs, so profit falls faster than volume in a downturn, and the company disclosed that weekly order intake fell about 24 percent after US aluminium tariffs rose to 50 percent in June 2025 and had not recovered by early 2026. The films business is also concentrated, with four customers accounting for roughly 13 percent of total sales, and management flags ageing plant and legacy systems that will require reinvestment, including a long-running systems project with about $21 million capitalised and not yet in service. The bull case assumes extrusion volumes recover and films returns to 2024 profitability, growing four percent a year and discounted at 8.5 percent, giving $17.96. We anchor the margin-of-safety price mainly on the bear case, blending in a minority weight of the base case because a full decade with no cyclical recovery at all is a stress test rather than a central expectation, and then apply a further 30 percent discount for the genuine uncertainty around end demand, customer concentration and future capital needs. That gives a margin-of-safety price of $3.43, a little over half of book value. We are reasonably but not highly confident in this range: the balance sheet is now clean and both businesses generate real cash, but neither has a durable competitive moat, and the gap between the bear and bull outcomes is wide.